Mammalian cells express three distinct dynein heavy chains that are localized to different cytoplasmic organelles by unknown
hh
That Are Localized to Different Cytoplasmic Organelles 
Eugeni A. Vaisberg, Paula M. Grissom, and J. Richard Mclntosh 
Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado 80309-0347 
Abstract. We describe two dynein heavy chain (DHC)- 
like polypeptides (DHCs 2 and 3) that are distinct from 
the heavy chain of conventional cytoplasmic dynein 
(DHC1) but are expressed in a variety of mammalian 
cells that lack axonemes. DHC2 is a distant member of 
the "cytoplasmic" branch of the dynein phylogenetic 
tree, while DHC3 shares more sequence similarity with 
dynein-like polypeptides that have been thought to be 
axonemal. Each cytoplasmic dynein is associated with 
distinct cellular organelles. DHC2 is localized predomi- 
nantly to the Golgi apparatus. Moreover, the Golgi dis- 
perses upon microinjection of antibodies to DHC2, sug- 
gesting that this motor is involved in establishing 
proper Golgi organization. DHC3 is associated with as 
yet unidentified structures that may represent transport 
intermediates between two or more cytoplasmic com- 
partments. Apparently, specific cytoplasmic dyneins, 
like individual members of the kinesin superfamily, 
play unique roles in the traffic of cytomembranes. 
M ICROTUBULE-dependent motor enzymes play crit- 
ical roles in many types of intracellular trans- 
port. There are two principal classes of microtu- 
bule motors: kinesins and dyneins. The kinesins comprise 
a superfamily of proteins, defined by sequence identity in 
a "motor domain." They are associated with a surprising 
diversity of cytoplasmic movements: spindle pole separa- 
tion, chromosome movement, axonal transport, Golgi ves- 
icle traffic, migrations in and out of axonemes, and proba- 
bly a wealth of additional movements that are still to be 
characterized (Goldstein, 1993; Skoufias and Scholey, 
1993). The family of dyneins is less diverse, but even so, it 
includes more than a dozen heavy chain polypeptides that 
contribute to making an axoneme (Gibbons et al., 1994; 
Rasmusson et al., 1994) and a cytoplasmic isoform that has 
been suggested to play roles in vesicle transport, mem- 
brane dynamics, chromosome movement, and the posi- 
tioning of some organelles (for review see Holzbaur and 
Vallee, 1994). 
The importance of dynein function in axoneme motility 
is unequivocal, but our understanding of dynein's role in 
intracellular motility is less complete. Several lines of evi- 
dence implicate this enzyme in retrograde axonal trans- 
port (Schroer, 1992). Localization studies have placed 
both the heavy chain and a 74-kD intermediate chain of 
cytoplasmic dynein at kinetochores, where a minus-end- 
directed motor enzyme could contribute to anaphase A 
(Steuer et al., 1990; Pfarr et al., 1990), but there is as yet no 
evidence that dynein plays such a role. Microinjection of 
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function-blocking antibodies raised against bacterially ex- 
pressed fragments of cytoplasmic dynein heavy chains from 
two species blocked the separation of mitotic centrosomes, 
but they had no effect on chromosome attachment to the 
spindle (Vaisberg et al., 1993). Genetic analysis of cyto- 
plasmic dynein function in fungi has implicated this en- 
zyme in both the positioning and the elongation of mitotic 
nuclei in Saccharomyces cerevisiae (Li et al., 1993) and in 
postmitotic nuclear movements in other fungi (Xiang et 
al., 1994; Plamann et al., 1994). Cytoplasmic dynein has also 
been implicated in the motion of vesicles derived from the 
Golgi apparatus to the centrosomal region of lysed cell 
models (Corthesy-Theulaz et al., 1992), and in the trans- 
port of endocytic vesicles (Bomsel et al., 1990; Fath et al., 
1994; Lafont et al., 1994; Oda et al., 1995), but the relation- 
ship between these in vitro systems and membrane move- 
ments in vivo is still undefined. 
The diversity of functions attributed to cytoplasmic dy- 
nein, together with the ineffectiveness of our motility- 
blocking dynein antibodies in disrupting both chromo- 
some movement and Golgi dynamics in vivo (Vaisberg, 
E.A., and J.R. Mclntosh, unpublished results), led us to 
suspect that cytoplasmic dynein might be more complex 
than was previously thought. We hypothesized that there 
were novel isoforms of cytoplasmic dynein involved in sev- 
eral aspects of cell motility, so experimental approaches 
focused on the one known isozyme were bound to fail. We 
have therefore undertaken a search for novel dynein heavy 
chains that are expressed in cells making neither cilia nor 
flagella. Here we report the identification of two such iso- 
forms, cytoplasmic dynein heavy chains (DHCs) 1 2 and 3 
1. Abbreviations used in this paper:. BFA, brefeldin A; DHC, dynein heavy 
chain; RT, reverse transcription. 
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edly from that of "conventional" cytoplasmic dynein heavy 
chain (DHC1) and from each other. DHC2 is associated 
predominately with the Golgi apparatus and is likely to be 
involved in the organization of this organelle. DHC3 local- 
izes to cytoplasmic structures that do not correspond well 
to any of the well-defined membranous compartments of 
cytoplasm. 
Materials and Methods 
Reagents and Antibodies 
Unless otherwise  specified, biochemical reagents were  purchased from 
Sigma Chemical Co. (St. Louis, MO). Enzymes for molecular biology were 
purchased from Promega Corp. (Madison, WI) or Boehringer Mannheim 
Biochemicals (Indianopolis, IN). The mAb p58-9 (Bloom and Brashear, 
1989)  was a  gift from Dr. G. Bloom (University of Texas Southwestern 
Medical Center, Dallas, TX); the mAb to mannose-6-phosphate receptor 
(Lombardi et al., 1993; Dintzis et al., 1994)  was a gift from Dr. S. Pfeffer 
(Stanford  University,  Stanford,  CA);  the  mAb  to  et-mannosidase  II 
(Burke et al., 1982) was purchased from BAbCO (Richmond, CA). Texas 
red-conjugated  human transferrin  vital  fixable  markers  for  lysosomes 
(LysoTracker Red DHD-99) and mitochondria (MitoTracker Green FM) 
were purchased from Molecular Probes, Inc. (Eugene, OR). 
Reverse Transcription, PCR, and Analysis of Clones 
Purification of mRNA, cDNA synthesis, and PCR with degenerate primers 
were performed as described previously (Vaisberg et al., 1993) with two mod- 
ifications: PCR was performed with an annealing temperature of 37°C, and 
the pDK101 vector (Kovalic et al., 1991) (No. 77406; American Type Culture 
Collection, Rockville, MD) was used to clone the resulting reaction products. 
RNA Walk, Library Screening, Molecular Biological 
Techniques, and Sequence Analysis 
A random primed eDNA library from a human adenocarcinoma cell line 
(Stratagene, La Jolla, CA) was screened with the DHCl-specific probe 
Hp22 (Vaisberg et al., 1993)  using the Genius 1 labeling system (Boeh- 
ringer Mannheim Biochemicals) according to the manufacturer's proto- 
col. eDNA for a 5' "walk" was primed with a degenerate oligonucleotide 
that encodes the MNPGYAG sequence (primer "b" in Vaisberg et al., 
1993).  Subsequent tailing with dCTP and amplification by two rounds of 
PCR with sequence-specific primers (1.1 and 1.2 for DHC1 and 2.1 and 2.2 
for DHC2; see Fig.  1 B)  and an anchor dG oligonucleotide were per- 
formed as described in (Lee et al., 1993), except dITP residues were incor- 
porated  into the adapter (Schuster et aL, 1992).  The resulting products 
were cloned into the pDK101 vector and sequenced using the ATaq Cycle 
Sequencing kit (United States Biochemical Corp., Cleveland, OH). 
To  account  for  possible  PCR  errors  during  reverse  transcription 
(RT)-PCR and RACE, sequences encoding DHC2 were verified by se- 
quencing three independently isolated clones. The sequence of the 3' 2 kb 
of the library clone for DHC1 was additionally verified by sequencing the 
corresponding RACE clone. Sequence alignment and analysis was per- 
formed using GCG Wisconsin Package Version 8.1-UNIX (Program Man- 
ual for the Wisconsin Package, Version 8, September 1994; Genetics Com- 
puter Group, Madison, WI). For Southern blot analysis, genomic DNA 
was isolated from HeLa cells as described in Sambrook et al. (1989). 20 p~g 
of human genomic DNA was digested with restriction endonucleases as 
indicgted, blotted, and hybridized with DHC probes at high stringency as de- 
scribed in Vaisberg et al. (1993).  For Northern blotting, total RNA was 
isolated using RNA Isolator (Genosys Biotechnologies Inc., The Wood- 
lands, TX). 10 Izg of RNA was separated on a 0.8% formaldehyde-dena- 
turing agarose gel, transferred to a  nylon membrane, and probed as de- 
scribed in Vaisberg et al. (1993). 
Preparation of  Immunogens, Purification of  Antibodies, 
and Immunoblotting 
cDNA clones used for the expression of the antigens were obtained by di- 
rect PCR from HeLa RNA using isoform-specific primers, thus minimiz- 
ing the possibility of accumulating PCR errors in cycles of amplification. 
The primer pairs used were: 1.6-1.3 to produce DHC1/1; 2.6-2.3 to pro- 
duce DHC2/1; 3.4-3.3 to produce both DHC3/1 and DHC3/2; and 1.5-1.4 
and 2.5-2.4 to produce DHCI/2 and DHC2/2, respectively (Fig.  1). The 
identity of the clones was verified by end sequencing. Gene fragments en- 
coding the antigens were cloned into the pET5b expression vector (Studier 
et al., 1990)  (DHC1/1, DHC1/2, DHC2/2, and DHC3/2) or pRSET vector 
(Invitrogen, San Diego, CA) (DHC2/1 and DHC3/1) and expressed in Es- 
cherichia  coil  strain  BL21(DE3).  Inclusion  bodies  containing  the  ex- 
pressed protein were purified (Lin and Cheng, 1991)  and fractionated by 
gel electrophoresis. Bands of expressed proteins were excised and electro- 
eluted using an Elutrap device (Schleicher & Schuell, Inc., Keene, NH). 
Immunization, preparation of columns for affinity depletion and purifi- 
cation,  and  chromatography  were  performed  as  previously  described 
(Vaisberg et al., 1993).  Serum from rabbits immunized with each of the 
smaller (see Fig. 4) DHC fragments was depleted for cross-reactivity with 
the two other isoforms by repeated passages through the columns with 
coupled larger fragments until no cross-reactivity was detected by immu- 
noblotting. This preparation was affinity purified on a  column with the 
larger antigen representing the same isoform used for immunization. For 
example, anti-DHC2 antibody was prepared by immunization of rabbits 
with DHC2/2 fragment, sequential immunodepletion of the resulting se- 
rum on columns with DHC1/1 and DHC3/1 polypeptides, and then affin- 
ity purification on the column with DHC2/1 polypeptide. Immunoblotting 
was performed with 4% dry milk as a blocking reagent and developed us- 
ing an ECL development reagent (Amersham Corp., Arlington Heights, 
IL) according to manufacturer's protocol. Antibodies to DHC1, 2. and 3 
were used at concentrations of 0.2-0.5 ~g/ml. 
Preparation of CeU Extracts and Fractionation on 
Sucrose Gradients 
HeLa and NRK cells were collected by scraping into ice-cold PBS; washed 
two times with PBS  and once with PME buffer (100 mM Pipes, 5 mM 
MgSO4, 1 mM EGTA, 1 mM DT'I?; pH 6.9); resuspended in PME, supple- 
mented with protease inhibitors (10 i~g/ml of leupeptin, pepstatin A, and 
aprotinin; 1 mM PMSF) to the final density 108 cells per ml; lysed by gen- 
tle sonication or by passing 10-15 times through a 26-gauge needle; and 
clarified  by centrifugation in  an  SS34  rotor  (Sorvall  Instruments Div., 
Newton, CT) at 17,000 g~v for 15 min. 250 I.tl of the resulting extract was 
loaded on the top of 5-20% gradient of sucrose in PME and centrifuged in 
an SW60Ti rotor (Beckman Instruments, Inc., Fullerton, CA) at 360,000 
gay for 5.2 h. Thyroglobulin (19S), catalase (llS), and cytochrome C (2.2S) 
were used as standards. Fractions from the gradients were analyzed by im- 
munoblotting as described above. 
Cell Culture, Immunofluorescence, and Microinjection 
NRK, COS-7, and HeLa cells were grown in DME (Sigma Chemical Co.), 
supplemented with 10% FCS (GIBCO BRL, Gaithersburg, MD), 50 U/ml 
penicillin G, and 50 U/ml streptomycin sulfate. A431 cells were grown in 
DME, supplemented with 10% calf serum (GIBCO BRL), and CFPAC-1 
cells were cultured in IMEM (Sigma Chemical Co.), supplemented with 
10% FCS. For immunofluorescence, cells were plated on glass coverslips, 
and allowed to grow for 24-36 h, fixed with 4% paraformaldehyde in PBS 
for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 5 rain, and 
processed for immunofluorescence as previously described (Nislow et al., 
1990). All anti-DHC antibodies were used at a concentration of 5-10 ~g/ml. 
During the course of this study we experimented with several fixation 
protocols for immunofluorescence. Our experience with the microtubule 
cytoskeleton had led us to favor fixation in cold (-20°C) methanol, usu- 
ally followed by cold acetone. Upon application of this protocol to cells 
destined for staining by DHC3 antibodies, we found label specifically as- 
sociated with mitochondria. Aldehyde fixation, followed by detergent per- 
meabilization, on the other hand, showed little or no such association. By 
comparing these localizations with various marker antibodies, we discov- 
ered  that cold  methanol fixation makes staining with  several markers, 
such as 13COP, congruent with mitochondrial markers, a result that is al- 
most certain to be erroneous. We therefore fixed specimens by ultrarapid 
freezing and freeze substitution. Cultured cells were plated upon formvar- 
coated, carbon-stabilized gold grids, as used for EM. Individual grids were 
plunge frozen in liquid ethane, freeze substituted in acetone at -90°C, and 
fixed  in  paraformaldehyde  and  glutaraldehyde  as  the  specimen  was 
warmed to 0°C; then the cells were rinsed in pure acetone, rehydrated in 
PBS,  and processed for immunofluorescence. These specimens showed 
the expected distributions for 13COP, mitochondrial, and Golgi markers, 
and DHC staining was far more similar to that described here with aide- 
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serving cytomembranes for immunofluorescent localization. 
Microinjection of antibodies to DHC2 and preimmune immunoglobu- 
lins (both at 4.7 mg/ml) was performed as previously described (Vaisberg 
et al., 1993). After injection, NRK cells were incubated at 37°C for 3 h, and 
then fixed and processed for immunostaining with antibody to ct-mannosi- 
dase II (FITC) and to the injected antibody (Texas red). The dispersion of 
the Golgi apparatus in injected and control cells was assessed by eye. 
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Figure 1. (A) Schematic representation of clones described in the paper. Black bar at top depicts a whole dynein heavy chain with four 
P-loops from the consensus sequence for ATP-binding marked with white. Lighter cross-hatched bars show the position and sizes of the 
initial PCR clones; darker spotted bars depict RACE clones; light gray bar indicates a clone obtained by cDNA library screening. (B) 
Deduced amino acid sequences for parts of DHC1 and DHC2. Shown below the sequences are the positions of oligonucleotide primers 
used for initial RT-PCR amplification (degenerate primers d.! and d.2), subsequent 5' RACE (primers 1.1,1.2, 2.1, 2.2), and amplifica- 
tion of cDNA for the expression of immunogens (primers 1.3~5 and 2.34). 
Vaisberg et al. Novel lsoforms of Cytoplasmic Dynein 833 Based on the morphology of the Golgi, cells were assigned to one of three 
classes:  not dispersed, dispersed, and unclear. The latter category com- 
prised a small minority of cells (10-15%) and was excluded from further 
analysis.  Confidence  intervals for the  percentage  of cells  with the  dis- 
persed Golgi were calculated  assuming a binominal distribution. 
Results 
Three lsoforms of Dynein Heavy Chain Are Expressed 
in Cells That Do Not Make Cilia or Flagella 
We have performed a rigorous screen for cytoplasmic DHCs 
by reverse transcription  of mRNA from HeLa cells, fol- 
lowed by the PCR (RT-PCR). HeLa cells do not form cilia 
or flagella, so it is likely that any dynein expressed in these 
cells performs a "cytoplasmic" function. 
The degenerate oligonucleotide primers used for RT-PCR 
were designed to amplify the most conserved region sur- 
rounding the P-loop of the presumed ATP-binding site of 
the DHC polypeptide (Fig. 1). The majority of ~250 inde- 
pendently cloned and sequenced RT-PCR products repre- 
sented  a  fragment of a  conventional  cytoplasmic dynein 
heavy chain (DHC1), identical to the previously described 
hp22 fragment of human cytoplasmic DHC (Vaisberg et 
al.,  1993).  Four  additional  clones,  however, encoded  dy- 
nein-related  polypeptides,  clearly different  from DHC1. 
Three of those identified DHC2 and one identified DHC3. 
While the PCR clones of DHCs 1, 2, and 3 were suffi- 
ciently distinct to show that they represented different hu- 
man genes, they were obtained from the most highly con- 
served  portions  of  the  dynein  heavy  chain  molecule, 
suggesting that we would need additional sequence infor- 
mation to  construct  isotype-specific reagents  for protein 
biochemical work. Comparisons of existing dynein heavy 
chain sequences revealed that the regions lying 5' from the 
sequences already in hand were the least conserved parts 
of  the  polypeptides,  so  we  employed  a  combination  of 
cDNA library screening and 5' RACE walking on cDNA 
from HeLa cells to obtain additional sequence (Fig. 1). 
The resulting DHC nucleotide sequences were used to 
make probes with which to study DHC genes and their ex- 
pression.  Southern  blot  analysis was  consistent  with  the 
notion that DHCs 1, 2, and 3 are the products of different 
unique  genes (Fig. 2 A), although an unambiguous inter- 
pretation of Southern blot data is complicated by the pres- 
ence of several introns of unknown sequence in the rele- 
vant region of genomic DNA  (Vaisberg, E.A.,  and P.M. 
Grissom, unpublished  observations). Northern blots with 
RNA isolated from several cell lines  and human tissues, 
including those that make neither cilia nor flagella, revealed 
bands hybridizing with each of the three dynein genes; all 
showed molecular sizes of ~15 kb (Fig.  2 B). In some cell 
lines  the  DHC1  probe  recognized  a  doublet  of mRNA 
bands, suggesting alternative splicings of this message. The 
levels of expression of the three DHCs varied significantly 
between different cells and tissues.  While DHC1 mRNA 
was prevalent in the majority of cells and tissues, DHC2 
predominated  in  COS cells,  and  DHC3 in  both foreskin 
and liver. These results confirm that all three dynein heavy 
chains are expressed in cells that do not make cilia or flagella. 
DHC2 Is a Distant Member of a Family of 
Cytoplasmic Dyneins,  while DHC3 Is More Similar to 
Axonemal Dyneins Than to Any of the Previously 
Identified Cytoplasmic Polypeptides 
The  amino acid  sequence  predicted  from the  cloned  re- 
gion of human DHC1 is almost identical to its rat counter- 
Figure 2. (A) Southern blot analysis of human genomic DNA probed with sequences from DHCs 1, 2, and 3. Enzymes used for diges- 
tion are shown on top of the lanes; positions of molecular size markers are indicated  at left. (B) Northern blots of RNA from monkey 
and human cell lines and human tissues probed with DHCls 2 and 3. Only the ~15-kb region of the gel is shown. No other regions 
bound the probe. 
The Journal of Cell Biology, Volume 133, 1996  834 part (Mikami et al., 1993; Zhang et al., 1993) (98.5% iden- 
tity).  Levels  of  pairwise  similarity  between  the  human 
DHCs in the regions from which sequence is available are 
presented in Table I. The similarity of DHCs 2  and 3  to 
DHC1 and to the DHCs from other species drops signifi- 
cantly towards the NH2 terminus of the predicted protein, 
as was observed from comparisons of cytoplasmic and ax- 
onemal dyneins (Koonce et al., 1992; Mikami et al., 1993; 
Zhang et al., 1993; Eshel et al., 1993; Li et al., 1993; Xiang 
et  al.,  1994;  Plamann  et  al.,  1994;  Mitchell  and  Brown, 
1994;  Lye et al., 1995;  Ogawa, 1991;  Gibbons et al., 1991; 
Kandl et al., 1995).  Nonetheless, amino acid residues con- 
served among recently identified members of a DHC fam- 
ily in sea urchin (Gibbons et al., 1994), Drosophila, and rat 
brain (Tanaka et al., 1995) are also conserved in DHCs 2 
and 3. In the region where DHC2 clones overlap with the 
short  PCR fragments obtained from sea urchin  embryos 
and rat brain, the sequence is most similar to that of DLP4 
from rat brain (Tanaka et al., 1995)  (100% identical) and 
DHC1B  (Gibbons  et  al.,  1994)  from sea  urchin  (91.7% 
identical).  Thus, DHC2 probably is a  human homologue 
of these  DHC-like polypeptides.  In  agreement with  the 
analysis by Tanaka et al. (1995) and Gibbons et al. (1994), 
based on shorter sequence fragments, DHC2 is a highly di- 
S.tL 8DHC 
Ca. czDHC 
P. BDHC 
DHC3 
AspefS~us 
N~pola 
DHCI 
C. elesms 
Pmmeci~ 
DHC2 
$.n 
Figure 3.  A  tree of sequence  similarities  showing human DHC 
isoforms with cytoplasmic dynein heavy chains from various  or- 
ganisms (Koonce et al., 1992; Mikami et al., 1993; Zhang et al., 
1993; Eshel et al., 1993; Li et al., I993; Lye et al., 1995; Xiang et 
al., 1994; Plamann et al., 1994; Kandl et al., 1995) and axonemal 
dynein heavy chains from sea urchin  (Ogawa,  1991; Gibbons et 
al., 1991) (S.u. [3DHC), Paramecium (Kandl  et  al.,  1995) (P. 
flDHC), and Chlamydomonas reinhardtii (Mitchell  and Brown, 
1994) (Ch. aDHC). The tree was generated using the Pileup pro- 
gram (using an UPGMA algorithm) from GCG with the follow- 
ing  parameters:  gap  creation  penalty  =  3.0; gap  extension 
penalty =  0.1. A  region of DHC corresponding to amino acids 
636-839 on Fig. 1 B was used for the comparison. 
Table I. Sequence Comparisons of  Human Cytoplasmic Dynein 
Isoforms 
DHC 1  DHC2  DHC3  [~DHC 
%  %  %  % 
42.7/60.2  36.9/54.2  39.0/58.6 
38.9/61.1  44.7/60.0 
NA  50.5/67.0 
31.8/52.1  NA 
DHC1 
DHC2  34.1/55.9 
DHC3  NA 
~DHC  31.1/55.5 
Sea urchin axonernal [3-dynein heavy chain (13DHC) is included for comparison. The 
first value in each box represents percent identity, and the second represents percent 
similarity between corresponding polypeptides. Comparisons in the upper-right part 
of the table are based on the region of DHC from amino acids 636-839 on Fig. 1 B. 
Comparisons in the lower left part of the table are based on a larger region from amino 
acids 1-839 on Fig. 1 B, for which DHC3 sequence information is not available. 
verged member of the cytoplasmic DHC family (Fig. 3 and 
Table I). 
DHC3 sequence is more similar to known axonemal dy- 
neins than to any of the cytoplasmic DHCs (Fig. 3 and Ta- 
ble I). It is most similar to dyneinlike protein 12 (DLP12) 
from rat brain  (Tanaka et al.,  1995)  (100%  identity in  a 
50-amino acid overlap) and to sea urchin DHC isotype 7C 
(DHC7C) (Gibbons et al., 1994) (93% identity over a 97- 
amino acid overlap). Based on sequence comparisons with 
known dynein heavy chains and, in the case of DHC7C, on 
the upregulation of mRNA upon sea urchin embryo decili- 
ation, these dynein isotypes previously have been consid- 
ered to be axonemal (Gibbons et al., 1994). 
DHC2 and DHC3 Polypeptides Are Expressed in a 
Variety of Mammalian Cell Lines 
To investigate the expression and function of these human 
cytoplasmic DHC isoforms, we have generated antibodies 
that would discriminate  among them. The lower level of 
similarity among the sequences in the segments upstream 
from the ATP-binding domain suggested that we could use 
this region to generate isoform-specific antibodies. None- 
theless,  we  anticipated  that  the  polypeptides  expressed 
from these  gene fragments might contain some common 
epitopes, so our strategy has been designed to allow both 
affinity purification  and  affinity depletion  of those  anti- 
Figure 4.  Diagram of the antigens used to produce and to purify 
antibodies.  Black  bar  at  top  depicts  the  whole  dynein  heavy 
chain. Smaller polypeptides denoted DHC1/2 (52 kD), DHC2/2 
(51 kD), and DHC3/2  (15 kD) (light gray bars) represent analo- 
gous regions  of DHC1, 2, and 3, as inferred by sequence  align- 
ment using several different alignment  algorithms.  Polypeptides 
used for the affinity purification  and depletion of the cross-reac- 
tive antibodies (DHC1/1 [67 kD], DHC2/1 [65.5 kD], and DHC3/1 
[17.3 kD; darker bars]) completely overlap with the region that 
encodes each immunogen; for DHC1 and 2, they also contain ex- 
tra sequences flanking the immunogen. 
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of the  isoforms.  Fig.  4  depicts  the  clones  that  were  ex- 
pressed in bacteria to generate the immunogens (light gray 
bars), as well as those that were used for subsequent affin- 
ity purification (darker bars). For DHCsl and 2, the latter 
polypeptides added sequences flanking the immunogen at 
both ends. By using smaller antigens for immunization and 
larger  ones  for immunodepletion,  we  ensured  that  anti- 
bodies to the common epitopes could be removed and that 
we could control for cross-reactivity of the resulting  anti- 
bodies by immunoblotting. 
The immunoblots presented in Fig. 5 A  demonstrate the 
lack  of  cross-reactivity  among  the  resulting  antibodies. 
Each of the antibodies  recognized only its corresponding 
polypeptide  (and  the  products  of  its  degradation),  but 
even  on overexposed blots,  they did not show reactivity 
with polypeptides from the other dynein isoforms. 
Immunoblotting  analysis  with  proteins  from  cultured 
mammalian cells showed that all three DHC polypeptides 
are  expressed  in HeLa,  NRK, PtK1,  and  COS-7 cells.  In 
cell lysates  these  antibodies  specifically recognized poly- 
peptides  with  molecular  masses  characteristic  of DHCs 
(Fig. 5 B).  In some cell lines the antibodies  detected two 
bands  of similar  molecular weight (i.e.,  DHC1  in  COS-7 
cells,  DHC2 in PtK  1 cells,  or DHC3  in NRK cells).  This 
complexity may result from alternative splicing, posttrans- 
lational modification of the DHCs, and/or the presence of 
additional cytoplasmic DHCs whose genes are not yet in 
Figure 5.  Antibodies raised against bacterially expressed fragments of human DHCs are isoform specific and recognize all three DHCs 
in lysates of several mammalian cell lines.  (A) Equal amounts of inclusion body protein isolated from bacteria-expressing fragments 
DHC1/1, DHC2/1, and DHC3/1 (lanes 1, 2, and 3, respectively) were separated by SDS-PAGE (left-most panel), transferred to nitrocel- 
lulose, and probed with affinity-purified anti-DHC1 (left panel), DHC2 (middle panel), or anti-DHC3 (right panel) antibodies. The posi- 
tions of the bands corresponding to each of the dynein antigens are marked between the panels. Positions of molecular weight markers 
are shown at right.  (B) All three isoforms are expressed in different mammalian cells but at different levels. 20 v.g of proteins from 
whole cell lysates was resolved by SDS-PAGE, transferred to nitrocellulose, and probed with one of the antibodies as indicated. Each of 
the antibodies reacts specifically  with a band, or a doublet of bands, with high apparent molecular mass characteristic of a DHC. (C) 
Fractionation of cell extracts on a 5-20% sucrose gradient. HeLa and NRK cell extracts were prepared and fractionated on sucrose gra- 
dients as described in Materials and Methods. Extracts (L), individual fractions of the gradients (numbered beginning at the bottom of 
the gradient), and pellets from the bottom of the gradients (P). Arrows below the panels indicate the positions of standards. 
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cell type to cell type, just like the levels of the correspond- 
ing mRNAs. Both DHC1  and 3 are expressed at highest 
levels in  NRK cells,  while  DHC2 is  expressed at  a  high 
level in COS fibroblasts. Since the immunoblots were probed 
with different antibodies and developed with different ex- 
posures, we  are unable to  draw  quantitative  conclusions 
about the absolute amounts of different DHC isoforms ex- 
pressed in different cells, but the relative level of each pro- 
tein in different cell types is consistent with the results of 
Northern blotting. For example, both mRNA and protein 
of DHC1 are expressed at higher levels in HeLa cells than 
in COS ceils, while both mRNA and protein of DHC2 are 
more abundant in COS fibroblasts than in HeLa cells. 
Molecules  of  all  characterized  species  of the  conven- 
tional cytoplasmic dynein (DHC1)  are comprised of two 
heavy chain polypeptides and  a  number of intermediate 
and  light  chains;  they  sediment  at  ,~20S  (Holzbaur  and 
Vallee, 1994). To get an initial insight into the structure of 
the molecules that contain DHC2 and DHC3, we exam- 
ined  the  sedimentation  of the  soluble  fraction  of these 
polypeptides on a 5-20% sucrose gradient (Fig. 5 C). Both 
DHC2 (~15S) and DHC3 (~13S) sedimented significantly 
slower  than  conventional  cytoplasmic dyneins,  implying 
different sizes and/or structures of the molecules. The low 
sedimentation coefficient of DHC3 suggests that this ho- 
loenzyme may contain only one heavy chain, unlike con- 
ventional cytoplasmic dynein but similar to some species 
of axonemal dyneins.  Under  the  conditions  used for this 
experiment (relatively high ionic strength PME buffer; see 
Materials and Methods), almost all DHC2 is soluble. The 
amount of DHC2 associated with membranes in cell lysates 
depended strongly on the ionic conditions and the divalent 
cation composition of the buffers used for homogenization 
(not shown). Much of the DHC3 remained associated with 
rapidly sedimenting particles, even at relatively high ionic 
strength (lane P  on Fig. 5 C). Detailed studies will be re- 
quired  to  address  the  important problem of the  mecha- 
nism by which different dynein isoforms associate with dif- 
ferent cellular membranes. 
Figure 6.  Immunolocalization of DHC2 in several cell lines. DHC2 is predominantly associated with the Golgi apparatus. NRK, COS7, 
and HeLa cells were costained  with DHC2 antibody (left panels) and one of the following Golgi markers as indicated: anti-o~-mannosi- 
dase II, mAb p58-9, or FITC-conjugated Lens culinaris lectin. 
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Participates in Proper Golgi Organization 
We used our isotype-specific antibodies to examine the in- 
tracellular  distribution  of each DHC in  several  mamma- 
lian cell lines and found that all three isoforms displayed 
distinct cytoplasmic localizations.  DHC1 localizations are 
similar  to  those  previously reported  for cytoplasmic dy- 
nein in cultured cells (Steuer et al., 1990; Pfarr et al., 1990). 
Interphase cells show a punctate staining of the cytoplasm, 
which  is  generally  brighter  in  the  perinuclear  area  and 
dimmer near  the  cell periphery.  As previously described 
Figure 7.  Effects of nocodazole and brefeldin A treatments on DHC2 localization in NRK cells. After the treatment indicated at left, 
NRK cells were fixed and processed for immunofluorescence with DHC2 antibody (left  panels) or anti-mannosidase II. 
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the kinetochores and mitotic spindle (not shown). 
The intracellular localization of DHC2 differs from that 
of DHC1. In all cell types examined (NRK, COS-I, HeLa, 
3T3, and BHK), it colocalizes mainly with markers for the 
Golgi apparatus,  although some cytoplasmic vesicles are 
also stained (Fig. 6). In fine details, however, Golgi local- 
ization of DHC2 is different from that of such markers as 
ct-mannosidase II, p58, or Lens culinaris lectin, suggesting 
that DHC2 is  associated only with a  subset of the Golgi 
compartments. 
Additional  evidence  about  the  relationship  between 
DHC2 and  the  Golgi apparatus  has been obtained by a 
pharmacological  investigation  of  DHC2's  colocalization 
with several Golgi markers during and after treatment of 
the cells with drugs. When cytoplasmic microtubules are 
depolymerized by Nocodazole, the Golgi apparatus loses 
its association with the centrosomal region and appears as 
small fragments scattered throughout the cytoplasm (for 
reviews see Thyberg and Moskalewski, 1985; Kreis, 1990). 
DHC2 remains associated with these scattered fragments 
(Fig. 7, top panels). 
The fungal metabolite brefeldin A  (BFA) inhibits mem- 
brane traffic between the Golgi and the ER. It causes fast 
(<15 s) dissociation of coatomer proteins from Golgi mem- 
branes (Donaldson et al., 1990), followed by an escape of 
Golgi membranes and proteins into the ER (for review see 
Klausner et al.,  1992).  In cells treated with BFA, DHC2 
disappears from the Golgi apparatus;  it reappears at the 
Golgi upon recovery from BFA with approximately the same 
kinetics as the cis-medial  Golgi enzyme et-mannosidase II 
(Fig. 7). The distribution of DHC2 in BFA-treated cells 
resembles that described for escaped Golgi proteins (e.g., 
Lippincott-Schwartz et  al.,  1990), suggesting that  during 
BFA treatment, this motor enzyme becomes at least par- 
tially associated with the ER. Loss of DHC2 localization 
from the Golgi depends upon active transport from Golgi 
to ER, because a block of the escape of Golgi material in 
BFA-treated cells by either low temperature (16°C) or mi- 
crotubule depolymerization with nocodazole causes DHC2 
to remain associated with the Golgi or its fragments (Fig. 7). 
From these results we infer that the proximity of DHC2 
and Golgi staining in normal ceils is not simply the result 
of the enzyme moving along microtubules to the centroso- 
real  region.  The  persistence  of  the  association  through 
drug treatment and recovery suggests that DHC2 partici- 
pates in ER to Golgi transport and/or in establishing the 
Golgi's organization in cells. 
To further test this hypothesis, we injected anti-DHC2 
antibody into NRK cells. In 43 -+ 12.4% of cells (n  =  62; 
P  =  0.05), this injection led to the dispersal of the Golgi 
(Fig. 8). The fraction of cells with dispersed Golgi upon in- 
jection with preimmune immunoglobulins at the same con- 
centration was similar to the fraction with dispersed Golgi 
Figure 8.  Microinjection of anti-DHC2 causes fragmentation  of the Golgi apparatus. NRK cells were injected with DHC2 antibody (at 
4.7 mg/ml), incubated at 37°C for 3 h, and processed for immunofluorescence with antibody to a-mannosidase  II (right panels). Injected 
ceils are outlined with a black line on left panels. 
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P  =  0.05 vs 15.4  +_ 6.4%; n  =  124; P  =  0.05). Thus, anti- 
body injection induced a 2.5-2.8-fold increase in the frac- 
tion  of cells  with  a  fragmented  Golgi apparatus.  Appar- 
ently the presence of active DHC2 is necessary for cells to 
maintain  the  normal  arrangement  of  their  Golgi  mem- 
branes. 
DHC3 
The  intracellular  localization  of DHC3  is  different  from 
that of both DHCs 1 and 2. In all the cell lines examined 
(COS-7, HeLa, PtK~, A431, and 3T3), antibodies to DHC3 
stained both small vesicles almost uniformly distributed in 
the cytoplasm and an accumulation of small vesicles or tu- 
bules that was usually located near the microtubule-orga- 
nizing center (Fig. 9). Unlike DHC1, "background" cyto- 
plasmic staining with anti-DHC3 was very low, even with 
fixation procedures that immobilize  a  significant fraction 
of the  soluble  cytoplasmic  proteins,  suggesting  that  the 
level of soluble  DHC3 in the cytoplasm is relatively low. 
This  observation is consistent with the sedimentation  be- 
havior of DHC3, which showed that a  significant fraction 
of DHC3 is  associated  with  the insoluble  fraction of the 
extract (see Fig. 5 C). 
We have performed either  double labeling or simulta- 
neous staining, using antibodies to DHC3 and a variety of 
markers  for different parts of the cytoplasmic membrane 
system.  From  this  work  it  is  evident  that  the  organelles 
that bind DHC3 are not congruent with any of the major 
cytoplasmic compartments:  mitochondria,  ER,  the  Golgi 
apparatus,  early or late  endosomes, or lysosomes (Fig.  9 
and not shown). Such a  localization is consistent with the 
hypothesis that DHC3 contributes to the transport system 
that  moves intermediate  structures  between  these  major 
cellular compartments. 
Discussion 
There Are Multiple Cytoplasmic Dynein Heavy Chains 
Our  RT-PCR  screen  has  identified  three  dynein  heavy 
chain-like proteins that are expressed in a wide variety of 
somatic  mammalian  cells.  Both  Northern  and  Western 
blotting confirm that all of these  dynein isoforms are ex- 
pressed in cells that do not appear to make either cilia or 
Figure 9.  Intracellular localization of DHC3 in COS and A431 cells. (Left panels) Staining with anti-DHC3. To identify early endo- 
somes, ceils were incubated for 15 min in DME supplemented with 0.2% BSA and 5 tLg/ml Texas red--conjugated transferrin, and then 
fixed for immunolocalization. Late endosomes were localized with an antibody to human EGF receptor after incubating A431 cells in 
DME with 0.1% calf serum for 12 h, DME with 0.2% BSA for 1 h, and treatment with EGF (at 100 ng/ml) for 30 min. 
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mic dynein that has already been studied extensively, the 
second (DHC2) contains sequence elements that have led 
to the suggestion that its homologues might be cytoplas- 
mic isoforms (Gibbons et al., 1994; Tanaka et al., 1995), 
while the  third (DHC3) is among a  group of sequences 
that previously have been interpreted as components of 
the axoneme. Moreover, the low sedimentation velocity of 
DHC3 is more similar to the sedimentation velocity of sin- 
gle-headed axonemal dyneins (Witman, 1989,  1992) than 
to double-headed cytoplasmic dynein. In its native form 
this polypeptide may be part of a bigger protein complex, 
not yet identified, that includes additional cytoplasmic dy- 
nein heavy chains. The more complete studies of multiple 
dynein isoforms recently published for sea urchins and ro- 
dent  brain  identified  several  DHC  sequences  that  are 
closely related to our DHC3, e.g., DHC7A and B  in sea 
urchin, DHC62B in Drosophila, and DLPs 3 and 7 in rat. 
We infer that there may be additional DHCs that, similar 
to DHC3 (and its homologues in other species), are com- 
ponents of dyneins that play roles in cytoplasmic motility 
(see e.g., Fig. 5 in Tanaka et al., 1995). 
An  axonemal assignment  for 11  of the  13 dynein iso- 
forms identified in sea urchins was made on the basis of an 
increase in their expression when blastomeres were decili- 
ated  (Gibbons  at  al,,  1994),  Homologues of the  human 
DHC3 isoform fulfilled this definition of an axonemal dy- 
nein and may contribute to axonemal function, as well as 
playing some role in intracellular transport. Alternatively, 
their increase in  expression upon  deciliation may result 
from the cell's need to increase its cytoplasmic transport 
capabilities at a time when axonemal precursors are trans- 
ferred to the cell surface and assembled to form cilia. Fur- 
ther work will be required to distinguish  between these 
possibilities. 
The Functions of Different Cytoplasmic  Dyneins 
DHC1 corresponds both in protein sequence and in local- 
ization to the cytoplasmic dynein previously studied by us 
(Pfarr et al.,  1990;  Lye et al.,  1987; Koonce et al.,  1992; 
Vaisberg et al., 1993) and others (Steuer et al., 1990; Hays 
et al., 1994; Mikami et al., 1993; Zhang et al., 1993; Eshel et 
al., 1993; Li et al., 1993; Xiang et al., 1994; Plamann et al., 
1994; Lye et al., 1995). Since this dynein isoform is com- 
paratively  well  characterized,  we  have  not  pursued  its 
function or localization in the current study. 
DHC 2 is likely to play a role in the organization and/or 
the function of the Golgi apparatus. A  role for dynein in 
Golgi function was  previously suggested by experiments 
using lysed cells and Golgi membrane fractions (Corthesy- 
Theulaz et al.,  1992).  However, antibodies raised in our 
lab that inhibited the motility of DHC1 both in vitro and 
in vivo (Vaisberg et al., 1993) failed to influence Golgi or- 
ganization, either in interphase, in cells recovering from 
Nocodazole treatment, or in postmitotic cells (Vaisberg, 
E.A., unpublished results). This result is compatible with 
the finding presented here that the isoform of cytoplasmic 
dynein involved in Golgi activity is the novel DHC2 and 
not the conventional cytoplasmic dynein isoform. 
This interpretation is supported both by the localization 
of DHC2 in normal and drug-treated cells and by the re- 
sponse of several cultured cell lines to injection of DHC2- 
specific  antibodies.  The  fraction  of  injected  cells  that 
showed Golgi dispersal was not large (~50%), but on the 
other hand, these antibodies were affinity purified for iso- 
type specificity, rather than a  function-perturbing effect. 
In sum, these data provide strong support for the hypothe- 
sis that DHC2 plays a role in Golgi organization. 
The same dynein isoform may also contribute to traffic 
to or from the  Golgi. The colocalization of DHC2 with 
a-mannosidase II during both prolonged treatments with 
brefeldin A  and during reversal of this treatment suggest 
that  this  motor  enzyme can  disperse  with  other  Golgi 
membrane components to the  ER.  The immunofluores- 
cence image  of fixed cells may represent  a  steady-state 
concentration distribution, in which the majority of dynein 
is  Golgi  resident,  while  some  functions  to  bring  mem- 
branes from some pre-Golgi compartments to the Golgi it- 
self. Further studies of fractionated cells may help to eluci- 
date the role that this motor enzyme plays in intracellular 
membrane traffic. 
The immunolocalization of DHC3 leaves the function of 
this motor enzyme an enigma. It may well act to bring ves- 
icles from one endomembrane compartment to another, 
but in the absence of a specific compartment assignment, it 
is  difficult to  design  simple  cell biological  experiments, 
such as antibody injection, that can elucidate the role this 
enzyme plays in membrane traffic. Future work will focus 
on the association of DHC3 with various endocytic com- 
partments  in  pulse-chase  experiments  that  could reveal 
some aspect of the enzyme's motor role. 
In conclusion, our data unambiguously identify three cy- 
toplasmic dynein heavy chains, each with a unique local- 
ization in several different cultured cell types. The phylo- 
genetic placement of DHC3 rather strongly suggests that 
there may be more cytoplasmic dyneins involved in other 
aspects of intracellular motility. It is now clear that  the 
problem of isoform diversity must be confronted for the 
family of cytoplasmic dyneins, as well as for the kinesin su- 
perfamily. When one adds to this the diversity recently es- 
tablished for the myosin superfamily, it becomes evident 
that cells have at their disposal an almost bewildering vari- 
ety of motor enzymes for moving their components. It re- 
mains a fascinating challenge to characterize this complex- 
ity  and  to  categorize  the  different  motions  that  are 
associated with each of these elements of the cytoplasmic 
machinery. 
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